BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32496906)

  • 21. Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells.
    Zheng L; Zhang Y; Liu G; Cheng S; Zhang G; An C; Sun S; Wang J; Pang B; Li S
    Anticancer Drugs; 2020 Jul; 31(6):601-608. PubMed ID: 32011366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells.
    Jiang Y; Bi Y; Zhou L; Zheng S; Jian T; Chen J
    BMC Complement Med Ther; 2024 Jan; 24(1):68. PubMed ID: 38297301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65.
    Su CC; Chien SY; Kuo SJ; Chen YL; Cheng CY; Chen DR
    Mol Med Rep; 2012 Apr; 5(4):1019-22. PubMed ID: 22246196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
    Deng H; Yu B; Li Y
    Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
    Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
    Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
    Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
    Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tanshinone IIA induces apoptosis in human oral cancer KB cells through a mitochondria-dependent pathway.
    Tseng PY; Lu WC; Hsieh MJ; Chien SY; Chen MK
    Biomed Res Int; 2014; 2014():540516. PubMed ID: 24900970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
    Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
    Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
    Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
    Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
    Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
    Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tanshinone IIA regulates CCl
    Li Q; Huang D; Liao W; Su X; Li J; Zhang J; Fang M; Liu Y
    J Biochem Mol Toxicol; 2024 Feb; 38(2):e23648. PubMed ID: 38348705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis.
    Li H; Wu M; Guo C; Zhai R; Chen J
    Am J Chin Med; 2022; 50(8):2125-2151. PubMed ID: 36309810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
    Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
    Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF‑κB signaling.
    Huang T; Zhang X; Wang H
    Mol Med Rep; 2020 Sep; 22(3):2386-2394. PubMed ID: 32705250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro.
    Chen X; Li Q; He Y; Du H; Zhan Z; Zhao H; Shi J; Ye Q; Hu J
    Anticancer Agents Med Chem; 2017; 17(9):1234-1242. PubMed ID: 26478521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.
    Kim JY; Song JJ; Kwon BM; Lee JD
    Mol Med Rep; 2015 Sep; 12(3):4604-4609. PubMed ID: 26080622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
    Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
    Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.